0000899243-23-002884.txt : 20230127
0000899243-23-002884.hdr.sgml : 20230127
20230127180726
ACCESSION NUMBER: 0000899243-23-002884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230125
FILED AS OF DATE: 20230127
DATE AS OF CHANGE: 20230127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pandite Arundathy N.
CENTRAL INDEX KEY: 0001827232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 23564662
MAIL ADDRESS:
STREET 1: 1018 W 11TH ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 512-900-4690
MAIL ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-25
0
0001680367
Shattuck Labs, Inc.
STTK
0001827232
Pandite Arundathy N.
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
0
1
0
0
Chief Medical Officer
Common Stock
2023-01-25
4
A
0
37875
0.00
A
175792
D
Stock Option (Right to Buy)
3.57
2023-01-25
4
A
0
69750
0.00
A
2033-01-25
Common Stock
69750
69750
D
Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer.
This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
/s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite
2023-01-27